TickerFactsScreenerDevelopers

Lineage Cell Therapeutics, Inc. (LCTX) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2008: -$4.35M2009: $11.05M2010: $49.43M2011: $41.46M2012: $24.29M2013: $42.26M2014: $62.72M2015: $76.45M2016: $130.51M2017: $164.26M2018: $92.25M2019: $111.25M2020: $95.13M2021: $90.90M2022: $71.94M2023: $62.02M2024: $77.01M2025: $43.35M$43.35M
2008Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$43.35M-43.7%
2024$77.01M+24.2%
2023$62.02M-13.8%
2022$71.94M-20.9%
2021$90.90M-4.4%
2020$95.13M-14.5%
2019$111.25M+20.6%
2018$92.25M-43.8%
2017$164.26M+25.9%
2016$130.51M+70.7%
2015$76.45M+21.9%
2014$62.72M+48.4%
2013$42.26M+74.0%
2012$24.29M-41.4%
2011$41.46M-16.1%
2010$49.43M+347.4%
2009$11.05M+354.1%
2008-$4.35M—